Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial
Authors
- Giacomo Garibotto (ORCID: https://orcid.org/0000-0001-6432-2429)
- Michela Piaggio
- Pasquale B. Esposito (ORCID: https://orcid.org/0000-0002-0834-5586)
- Francesca Cappadona (ORCID: https://orcid.org/0009-0008-8264-5318)
- Francesca Viazzi (ORCID: https://orcid.org/0000-0003-4219-7043)
- Lucia Macciò (ORCID: https://orcid.org/0009-0006-7018-6367)
- Elisa Russo (ORCID: https://orcid.org/0000-0003-1279-3178)
- Daniela Verzola (ORCID: https://orcid.org/0000-0002-2790-5876)
- Giuseppe Chirco
- Julie Di Vincenzo
Institutions
- Ospedale Policlinico San Martino (IT)
- University of Genoa (IT)
Publication Details
- Journal
- High Blood Pressure & Cardiovascular Prevention
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1007/s40292-025-00764-3
- Citations
- 1
- Primary Topic
- Cardiovascular Health and Disease Prevention
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- AstraZeneca